News
An estimated 18,000 people in the United States annually suffer from new injuries to their spinal cords. Unfortunately for ...
Zai Lab Limited (NASDAQ:ZLAB) said on Monday that China’s National Medical Products Administration has accepted the label ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has ...
The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...
11d
Zacks Investment Research on MSNBayer Obtains Full FDA Approval for Oncology Drug VitrakviBayer BAYRY announced that the FDA has granted full approval to oncology drug, Vitrakvi (larotrectinib), a first-in-class TRK ...
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer ...
The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on ...
Cogent Biosciences, Inc.’s COGT share price has dipped by 11.10%, which has investors questioning if this is right time to ...
ArriVent BioPharma, Inc.’s AVBP share price has surged by 6.01%, which has investors questioning if this is right time to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results